Inventor
ZHU ZHENPING
US19 patents
⚠️ This page may combine multiple inventors who share the name “ZHU ZHENPING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD
8 patentsUS12269886B2Apr 8, 2025
Tetravalent bispecific antibody against PD-1 and PD-L1
SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD2 citations69
US11667717B2Jun 6, 2023
Antibodies binding to human IL-4R, preparation method therefor and use thereof
SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD3 citations67
US12319748B2Jun 3, 2025
Antibody binding to human HER2 and preparation method and use thereof
SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD0 citations59
US12509528B2Dec 30, 2025
Antibody binding to human CD38, preparation method thereof, and use thereof
SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD0 citations58
US12351612B2Jul 8, 2025
Method for preparing recombinant human nerve growth factor
SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD0 citations58
US11370836B2Jun 28, 2022
Monoclonal antibody binding to human IL-5, preparation method therefor and use thereof
SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD0 citations58
US11254746B2Feb 22, 2022
Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof
SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD0 citations47
US12384853B2Aug 12, 2025
Anti-HER2/PD1 bispecific antibody
SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD0 citations43
KADMON CORP LLC
6 patentsUS10407502B2Sep 10, 2019
Immunomodulatory agents
KADMON CORP LLC7 citations78
US11633475B2Apr 25, 2023
Human anti-VEGFR-2/KDR antibodies
KADMON CORP LLC0 citations61
US10588968B2Mar 17, 2020
Human anti-VEGFR-2/KDR antibodies
KADMON CORP LLC0 citations51
US10364291B2Jul 30, 2019
Human anti-VEGFR-2/KDR antibodies
KADMON CORP LLC0 citations46
US10023640B2Jul 17, 2018
Human anti-VEGFR-2/KDR antibodies
KADMON CORP LLC0 citations46
US10125144B2Nov 13, 2018
Rho kinase inhibitors
KADMON CORP LLC0 citations40